Anti-Recombinant-SARS-CoV-2 Spike RBD antibody [36A7]
| Catalog Number | Pack Size | List Price* | Quantity | |
|---|---|---|---|---|
| STJA0002930-100uG | 100 µg | 755,00 | Add | |
| STJA0002930-500uG | 500 µg | 1'159,00 | Add | |
| STJA0002930-1MG | 1000 µg | 1'664,00 | Add |
* CHF, excl. 8.1% VAT and shipping costs
Product Description
SARS-CoV-2 Spike RBDNeutralizing properties: blocks S1 and ACE2 binding in Octet system; IC50 1250 ng/ml measured in live virus neutralization assay
| Category | Antibody |
| Supplier | St Johns Laboratory |
| Application | EL, WB |
| Regulatory Status | RUO |
| Immunogen | Recombinant SARS-CoV-2 RBD2 protein produced by CHO-based proprietary suspension cell line. |
| Clone Number | [36A7] |
| Isotype | IgG1,l |
| Crossreactivity | Virus |
| Clonality | Mab |
| Format | PBS pH 7.4 |
| Working Dilution | Indirect ELISA 0.04 – 0.08 ng/ml |
| Purity | Protein A affinity chromatography following desalting |
| Conjugation | Unconjugated |
| Storage Conditions | The product is stable at 4 °C for several days. Store at-20 °C to-70 °C long term. Avoid multiple freeze-thaw cycles. |
| Product Line | Coronavirus |
| Tech. Data Sheet | View datasheet |
| Link To Supplier | https://www.stjohnslabs.com |
| Material Safety Data Sheet | Download PDF |
